|
|
|
|
The age-dependent decrease of whole brain N-acetylaspartate (WBNAA) in the patients suggests that progressive neuronal cell loss is a cardinal feature of this disease. WBNAA offers a quick, highly reproducible measure of disease progressio n and may be an important marker of treatment efficacy in MS as well as other neurodegenerative diseases. |
|